X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13173) 13173
Book Review (1788) 1788
Publication (855) 855
Conference Proceeding (50) 50
Book Chapter (27) 27
Magazine Article (13) 13
Dissertation (7) 7
Book / eBook (2) 2
Web Resource (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11908) 11908
humans (11675) 11675
female (7000) 7000
oncology (6438) 6438
taxoids - administration & dosage (5692) 5692
middle aged (5609) 5609
male (5383) 5383
docetaxel (5125) 5125
aged (5050) 5050
antineoplastic combined chemotherapy protocols - therapeutic use (4997) 4997
chemotherapy (4241) 4241
adult (4009) 4009
taxoids - therapeutic use (3233) 3233
cancer (3184) 3184
breast neoplasms - drug therapy (3083) 3083
treatment outcome (2978) 2978
taxoids (2666) 2666
paclitaxel (2383) 2383
taxoids - adverse effects (2061) 2061
antineoplastic agents - therapeutic use (1990) 1990
animals (1928) 1928
antineoplastic combined chemotherapy protocols - adverse effects (1921) 1921
paclitaxel - analogs & derivatives (1900) 1900
taxoids - pharmacology (1756) 1756
breast cancer (1751) 1751
breast neoplasms - pathology (1689) 1689
pharmacology & pharmacy (1650) 1650
lung neoplasms - drug therapy (1646) 1646
cisplatin - administration & dosage (1542) 1542
cell line, tumor (1523) 1523
neoplasm staging (1523) 1523
paclitaxel - administration & dosage (1496) 1496
disease-free survival (1457) 1457
drug administration schedule (1406) 1406
aged, 80 and over (1388) 1388
carcinoma, non-small-cell lung - drug therapy (1330) 1330
care and treatment (1322) 1322
therapy (1299) 1299
cisplatin (1266) 1266
deoxycytidine - analogs & derivatives (1248) 1248
prostatic neoplasms - drug therapy (1229) 1229
mice (1185) 1185
antineoplastic agents - administration & dosage (1182) 1182
trial (1162) 1162
fluorouracil - administration & dosage (1150) 1150
prostate cancer (1130) 1130
antineoplastic agents - pharmacology (1122) 1122
medicine & public health (1107) 1107
prognosis (1099) 1099
antineoplastic combined chemotherapy protocols - administration & dosage (1096) 1096
survival rate (1086) 1086
retrospective studies (1071) 1071
antineoplastic agents, phytogenic - therapeutic use (1047) 1047
research (1037) 1037
carcinoma (1022) 1022
survival (1013) 1013
survival analysis (988) 988
antineoplastic agents (984) 984
neoplasm metastasis (982) 982
deoxycytidine - administration & dosage (977) 977
drug resistance, neoplasm (976) 976
analysis (965) 965
metastasis (949) 949
dose-response relationship, drug (942) 942
chemotherapy, adjuvant (935) 935
paclitaxel - therapeutic use (930) 930
antimitotic agents (894) 894
antineoplastic agents - adverse effects (827) 827
neoadjuvant therapy (817) 817
combined modality therapy (809) 809
taxoids - chemistry (804) 804
lung neoplasms - pathology (796) 796
hematology, oncology and palliative medicine (789) 789
doxorubicin (762) 762
paclitaxel - adverse effects (735) 735
taxol (734) 734
phase-ii trial (731) 731
drug therapy (729) 729
antineoplastic agents, phytogenic - administration & dosage (727) 727
adenocarcinoma - drug therapy (722) 722
expression (709) 709
apoptosis (684) 684
prostatic neoplasms - pathology (684) 684
disease progression (672) 672
taxanes (670) 670
combination (657) 657
tumors (652) 652
neoplasms - drug therapy (651) 651
apoptosis - drug effects (648) 648
breast-cancer (645) 645
stomach neoplasms - drug therapy (643) 643
taxoids - pharmacokinetics (643) 643
follow-up studies (631) 631
phase-ii (619) 619
carcinoma, non-small-cell lung - pathology (617) 617
cyclophosphamide - administration & dosage (617) 617
paclitaxel - pharmacology (602) 602
doxorubicin - administration & dosage (596) 596
antineoplastic agents, phytogenic - adverse effects (592) 592
carboplatin - administration & dosage (592) 592
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11881) 11881
Japanese (617) 617
Chinese (231) 231
French (183) 183
German (116) 116
Russian (43) 43
Italian (34) 34
Spanish (31) 31
Hungarian (20) 20
Polish (9) 9
Dutch (8) 8
Korean (6) 6
Portuguese (5) 5
Czech (4) 4
Danish (4) 4
Lithuanian (4) 4
Finnish (2) 2
Hebrew (2) 2
Turkish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Croatian (1) 1
Norwegian (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10027, pp. 1540 - 1550
Summary Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for... 
Internal Medicine | CRITERIA | MEDICINE, GENERAL & INTERNAL | ANTI-PD-L1 ANTIBODY | THERAPY | NSCLC | IMMUNOTHERAPY | PD-L1 | BLOCKADE | NIVOLUMAB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Slopes | Cell survival | Medical treatment | Medical services | FDA approval | Survival | Patients | Medical centres | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers | Index Medicus | Abridged Index Medicus
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 05/2010, Volume 21, Issue 5, pp. 979 - 987
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 34, Issue 1, pp. 251 - 261
Abstract Fullerene (C60) has shown great potential in drug delivery. In this study, firstly, amine-functionalized C60 (C60-NH2 ) was achieved by introducing... 
Advanced Basic Science | Dentistry | PEI-derivatized fullerene | Drug delivery | Tumor-targeting | Nanoparticle | Folic acid | Docetaxel | CELLS | OXIDATIVE STRESS | MATERIALS SCIENCE, BIOMATERIALS | NEOADJUVANT TREATMENT | ENGINEERING, BIOMEDICAL | FOLIC-ACID | CARBON NANOTUBES | BREAST-CANCER | NANOPARTICLES | IN-VITRO | C-60 | Neoplasms - metabolism | Taxoids - pharmacology | Apoptosis - drug effects | Humans | Body Weight - drug effects | Male | Spectroscopy, Fourier Transform Infrared | Polyethyleneimine - pharmacokinetics | Neoplasms - blood | Polyethyleneimine - chemistry | Female | Folic Acid - chemical synthesis | Fullerenes - chemistry | Taxoids - blood | Polyethyleneimine - chemical synthesis | Taxoids - chemistry | Tissue Distribution - drug effects | Endocytosis - drug effects | Folic Acid - chemistry | Folic Acid - pharmacokinetics | Spectrophotometry, Ultraviolet | Taxoids - pharmacokinetics | Particle Size | Xenograft Model Antitumor Assays | Administration, Intravenous | Animals | Tumor Burden - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Neoplasms - pathology | Drug Delivery Systems - methods | Fullerenes - pharmacokinetics | Drugs | Drug delivery systems | Biological products | Heterocyclic compounds | Analysis | Polymerization | Ethylenediamines | Tumors | Vehicles | Index Medicus
Journal Article
Journal Article
Science, ISSN 0036-8075, 2/2013, Volume 339, Issue 6119, pp. 587 - 590
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 10/2014, Volume 474, Issue 1-2, pp. 112 - 122
Journal Article